Imbalance of receptor-regulated and inhibitory smads in lung fibroblasts from bleomycin-exposed rats

American Journal of Respiratory Cell and Molecular Biology

Volumn 36, Issue 2, 2007, Pages 206-212

  Gonzalez, Anne V ^a   Le Bellego, Frédérique ^a   Ludwig, Mara S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bleomycin; Lung fibrosis; Transforming growth factor

Indexed keywords

ACTIN; BLEOMYCIN; DACTINOMYCIN; MESSENGER RNA; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FIBROSING ALVEOLITIS; LUNG FIBROBLAST; LUNG TOXICITY; MALE; NONHUMAN; PHENOTYPE; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLEOMYCIN; CELL SEPARATION; CELLS, CULTURED; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG; MALE; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SMAD PROTEINS, INHIBITORY; SMAD PROTEINS, RECEPTOR-REGULATED; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

RATTUS;

EID: 33846914862     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2006-0132OC     Document Type: Article

References (37)

1. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-525.
2. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000;161:646-664.
3. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
4. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005;33:9-13.
5. Blobe GC, Schirmann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000;342:1350-1358.
6. Bartram U, Speer CP. The role of transforming growth factor β in lung development and disease. Chest 2004;125:754-765.
7. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88:6642-6646.
8. Sime PJ, Xing Z, Graham FL, Gauldie J. Adenoviral-mediated gene transfer of active TGF-β1 induces prolonged aggressive fibrosis in rat lung. J Clin Invest 1997;100:768-776.
9. Giri SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor-beta on bleomycin-induced accumulation of lung collagen in mice. Thorax 1993;48:956-966.
10. Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN. Reduction of bleomycin-induced lung fibrosis by TGF-β soluble receptor in hamsters. Thorax 1999;54:805-812.
11. KoIb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, Gauldie J. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 2001;163:770-777.
12. Heldin CH, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through Smad proteins. Nature 1997;390:465-471.
13. Shi Y, Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
14. Venkatesan N, Roughley PJ, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-β1 and interferon-γ. Am J Physiol Lung Cell Mol Physiol 2002;283:L806-L814.
15. Venkatesan N, Pini L, Ludwig MS. Changes in Smad expression and subcellular localization in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2004;287:L1342-L1347.
16. Phan SH, Varani J, Smith D. Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J Clin Invest 1985;76:241-247.
17. Selman M, King TE Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151.
18. Ebihara T, Venkatesan N, Tanaka R, Ludwig MS. Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2000;162:1569-1576.
19. Borzone G, Moreno R, Urrea R, Meneses M, Oyarzún M, Lisboa C. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;163:1648-1653.
20. Snider GL, Celli BR, Goldstein RH, O'Brien JJ, Ludey EC. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 1978;117:289-297.
21. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Palhol 2004;85:47-64.
22. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/ promoter transactivation approach. J Biol Chem 2001;278:17058-17062.
23. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad3. J Invest Dermatol 1999;112:49-57.
24. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al. Identification of Smad7, TGF-β inducible antagonist of TGF-β signalling. Nature 1997;389:631-635.
25. Nakao A, Sagara H, Setoguchi Y, Okada T, Okumura K, Ogawa H, Fukuda T. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol 2002;110:873-878.
26. Dong C, Zhu S, Wand T, Yoon W, Li Z, Alvarez RJ, ten Dijke P, While B, Wigley FM, Goldschmidt-Clermont PJ. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002;99:3908-3913.
27. Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J. Sustained activation of fibroblast transforming growth factor-β/Smad signaling in a murine model of scleroderma. J Invest Dermatol 2003;121:41-50.
28. Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, Oda T, Uchida C, Kitagawa K, Hattori T, Suzuki S, et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci USA 2004;101:8687-8692.
29. Wang B, Hao J, Jones SC, Yee MS, Roth JC, Dixon IM. Decreased Smad7 expression contributes to cardiac fibrosis in the infarcted rat heart. Am J Physiol Heart Circ Physiol 2002;282:H1685-H1696.
30. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Frideman SL, King TE Jr, Leinwand LA, et al. Future research directions in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002;166:236-246.
31. Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, Frederick JP, Wand XF, Warburton D. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002;282:L585-L593.
32. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Mihazono K, Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999;104:5-11.
33. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002;13:1464-1472.
34. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, ten Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178-191.
35. Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S, et al. Amelioration of radiation-induced fibrosis. Inhibition of transforming growth factor-β signaling by halofuginone. J Biol Chem 2004;279:15167-15176.
36. Nagler A, Firman N, Feferman R, Cotev S, Pines M, Shoshan S. Reduction in pulmonary fibrosis in vivo by halofuginone. Am J Respir Crit Care Med 1996;154:1082-1086.
37. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, et al. Progressive Transforming Growth Factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Cell Mol Biol 2004;171:889-898.